Monocytes from patients with myelodysplastic syndromes are activated and their inhibitory effect on hematopoiesis can be overcome by blocking the CD40 receptor

被引：0
|
作者：
Meers, S.
Boon, L.
Lemmens, J.
Verfaillie, C.
Verhoef, G.
Delforge, M.
机构：
来源：
ACTA CLINICA BELGICA | 2007年 / 62卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：250 / 250
页数：1
相关论文
共 32 条
  • [1] Monocytes are activated in patients with myelodysplastic syndromes and can contribute to bone marrow failure through CD40–CD40L interactions with T helper cells
    S Meers
    A Kasran
    L Boon
    J Lemmens
    C Ravoet
    M Boogaerts
    G Verhoef
    C Verfaillie
    M Delforge
    Leukemia, 2007, 21 : 2411 - 2419
  • [2] Monocytes are activated in patients with myelodysplastic syndromes and can contribute to bone marrow failure through CD40-CD40L interactions with T helper cells
    Meers, S.
    Kasran, A.
    Boon, L.
    Lemmens, J.
    Ravoet, C.
    Boogaerts, M.
    Verhoef, G.
    Verfaillie, C.
    Delforge, M.
    LEUKEMIA, 2007, 21 (12) : 2411 - 2419
  • [3] The CD40-Receptor is Upregulated on monocytes from patients with low-risk myelodysplastic syndromes and its inhibition by a monoclonal anti-CD40 antibody can increase colony formation.
    Meers, Stef
    Kasran, Ahmad
    Boon, Louis
    Boogaerts, Marc
    Vandenberghe, Peter
    Verhoef, Gregor
    Verfaillie, Catherine
    Delforge, Michel
    BLOOD, 2006, 108 (11) : 746A - 746A
  • [4] Downregulation of CD40 Ligand Response in Monocytes from Sepsis Patients
    Sinistro, Anna
    Almerighi, Cristiana
    Ciaprini, Chiara
    Natoli, Silvia
    Sussarello, Emanuele
    Di Fino, Sara
    Calo-Carducci, Francesca
    Rocchi, Giovanni
    Bergamini, Alberto
    CLINICAL AND VACCINE IMMUNOLOGY, 2008, 15 (12) : 1851 - 1858
  • [5] Fcγ Receptor Dependency of Agonistic CD40 Antibody in Lymphoma Therapy Can Be Overcome through Antibody Multimerization
    White, Ann L.
    Dou, Lang
    Chan, H. T. Claude
    Field, Vikki L.
    Mockridge, C. Ian
    Moss, Kane
    Williams, Emily L.
    Booth, Steven G.
    French, Ruth R.
    Potter, Elizabeth A.
    Butts, Cherie
    Al-Shamkhani, Aymen
    Cragg, Mark S.
    Verbeek, J. Sjef
    Johnson, Peter W. M.
    Glennie, Martin J.
    Beers, Stephen A.
    JOURNAL OF IMMUNOLOGY, 2014, 193 (04): : 1828 - 1835
  • [6] CD40 ligand (CD40L) from activated platelets induces tissue factor expression in monocytes in vitro.
    Armirkhosravi, A
    Amaya, M
    Francis, J
    BLOOD, 2000, 96 (11) : 16A - 17A
  • [7] Inhibitory Effect of Clopidogrel on Release of Soluble CD40 Ligand by ADP-activated Platelet in Patients With Non-ST-segment-elevation Acute Coronary Syndromes
    魏薇
    罗初凡
    杜志民
    South China Journal of Cardiology, 2008, (02) : 66 - 70
  • [8] The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes
    Yan, JC
    Zhu, H
    Gao, L
    Wu, ZG
    Kong, XT
    Zon, RQ
    Zhan, LZ
    CLINICA CHIMICA ACTA, 2004, 343 (1-2) : 155 - 159
  • [9] Aberrant expression of the costimulatory molecule CD40 ligand on monocytes from patients with systemic lupus erythematosus
    Katsiari, CG
    Liossis, SNC
    Souliotis, VL
    Dimopoulos, AM
    Manoussakis, MN
    Sfikakis, PP
    CLINICAL IMMUNOLOGY, 2002, 103 (01) : 54 - 62
  • [10] DEPLETION OF PROINFLAMMATORY MONOCYTES AND INCREASED LEVELS OF CD56 EXPRESSION ON CLASSICAL MONOCYTES IN THE PERIPHERAL FROM PATIENTS WITH LOWER RISK MYELODYSPLASTIC SYNDROMES
    Aires, A.
    Moreira, C.
    Cabral, R.
    Goncalves, M.
    Jorge, A. S.
    Mesquita, V.
    Queirs, M. L.
    Mota, A.
    Goncalves, C.
    Pinho, L.
    Xavier, L.
    Coutinho, J.
    Freitas, I.
    Lau, C.
    Teixeira, M. D. A.
    Lima, M.
    HAEMATOLOGICA, 2016, 101 : 768 - 768
1234